<DOC>
	<DOCNO>NCT00432042</DOCNO>
	<brief_summary>Primary Objective : - To demonstrate ProQuad® administer concomitantly booster dose Infanrix® hexa healthy child 12 23 month age without impair either antibody response rate measles , mumps , rubella , varicella , hepatitis B Haemophilus influenzae type b ; 3 pertussis antibody titres measure 42 day follow vaccination . Secondary Objectives : - To describe antibody titre antibody response rate measles , mumps , rubella , varicella , diphtheria , tetanus , pertussis , hepatitis B , poliomyelitis Haemophilus influenzae type b measure 42 day follow vaccination Infanrix® hexa primary series schedule data pool . - To evaluate safety profile ProQuad® administer concomitantly booster dose Infanrix® hexa Infanrix® hexa primary series schedule data pool .</brief_summary>
	<brief_title>Immunogenicity Safety Study Proquad® Infanrix® Hexa When Administered Concomitantly</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Measles</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Poliomyelitis</mesh_term>
	<mesh_term>Rubella</mesh_term>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Haemophilus Infections</mesh_term>
	<criteria>Healthy subject either gender Aged 12 23 month No clinical history measles , mumps , rubella , varicella zoster For Italy : Primary vaccination combine diphtheria , tetanus , pertussis , hepatitis B , poliomyelitis Haemophilus influenzae type b vaccine Infanrix® hexa 2dose schedule , receipt second dose ≥ 6 month prior inclusion For Germany : Primary vaccination combine diphtheria , tetanus , pertussis , hepatitis B , poliomyelitis Haemophilus influenzae type b vaccine Infanrix® hexa 3dose schedule , receipt third dose ≥ 6 month prior inclusion Consent form sign parent ( ) accord local regulation legal representative properly inform study Parent ( ) /legal representative able understand protocol requirement fill Diary Card . Prior receipt measles , mumps , rubella and/or varicella vaccine either alone combination Any recent ( &lt; = 30 day ) exposure measles , mumps , rubella , varicella and/or zoster Receipt diphtheria , tetanus , pertussis , hepatitis B , poliomyelitis and/or Haemophilus influenzae type b contain vaccine ( either alone combination ) Infanrix® hexa Any recent ( &lt; = 3 day ) history febrile illness Any severe chronic disease Active untreated tuberculosis Known personal history encephalopathy , seizure disorder progressive , evolve unstable neurological condition Any know blood dyscrasia , leukemia , lymphomas type , malignant neoplasm affect haematopoietic lymphatic system Any severe thrombocytopenia coagulation disorder would contraindicate intramuscular injection Prior know sensitivity/allergy component vaccine include neomycin , sorbitol gelatin Any immune impairment humoral/cellular deficiency , neoplastic disease depress immunity Any recent ( &lt; = 2 day ) tuberculin test schedule tuberculin test Visit 2 Any previous ( &lt; = 150 day ) receipt immune serum globulin bloodderived product schedule administer Visit 2 Any recent ( &lt; = 30 day ) receipt inactivate live nonstudy vaccine schedule nonstudy vaccination Visit 2</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>23 Months</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Mumps Rubella</keyword>
	<keyword>Haemophilus influenzae type b ( Infanrix® hexa )</keyword>
</DOC>